DJIA 17,070.50 -0.72 0.00%
NASDAQ 4,497.13 -8.73 -0.19%
S&P 500 1,975.47 -2.33 -0.12%
market minute promo

Novo Nordisk (NYSE: NVO)

47.74 -0.66 (-1.36%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

NVO $47.74 -1.36%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $47.70
Previous Close $48.40
Daily Range $47.65 - $47.80
52-Week Range $32.55 - $49.11
Market Cap $131.3B
P/E Ratio 0.00
Dividend (Yield) $0.61 (1.3%)
Ex-Dividend Date
Dividend Pay Date
Volume 178,101
Average Daily Volume 1,024,010
Current FY EPS $1.79





Novo Nordisk (NVO) Description

Engaged in discovery, development, manufacturing and marketing of pharmaceutical products and has two business segments - diabetes care and biopharmaceuticals. Website:

News & Commentary

Why Novo Nordisk Stock Is Better Than the Best

Three reasons make Novo Nordisk a must-have company in your stock portfolio.

Today's Stocks Driving Success For The Drugs Industry

Novo Nordisk Reveals Fresh Data on Xultophy for Diabetes - Analyst Blog

China Biologic Presents A Unique Investment Opportunity

3 Best Stocks to Invest in Pharma

AbbVie, Novo Nordisk, and Johnson & Johnson are three top healthcare stocks poised to delight investors for years to come

Sector Update: Health-Care Shares Lower in Pre-Market Trade

Sector Update: Health Care

Insider Buys at Halozyme Look to Improve Stock Outlook

Novo Nordisk A/S (NVO) Reaches New Lifetime High Today

Novo Nordisk's Tresiba Effective in Children & Adolescents - Analyst Blog

See More NVO News...

NVO's Top Competitors

NVO $47.74 (-1.36%)
Current stock: NVO
JNJ $106.71 (0.16%)
Current stock: JNJ
NVS $94.29 (0.78%)
Current stock: NVS
RHHBY $36.90 (0.00%)
Current stock: RHHBY